pulmicort and Mucocele

pulmicort has been researched along with Mucocele* in 1 studies

Other Studies

1 other study(ies) available for pulmicort and Mucocele

Article	Year
Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2008, Volume: 106, Issue:1 Local immunosuppressive therapies without systemic effects represent a therapeutic advantage in management of immune/inflammatory oral mucosal conditions. Topical budesonide rinses were prescribed to patients with mucosal disease that was resistant to other intervention without side effects. A case of paraneoplastic pemphigus and a patient with oral graft-versus-host disease that had not responded to standard approaches to management were successfully managed with budesonide rinse application. The cases presented represent mucosal conditions that were successfully managed with topical application of budesonide with reduced risk of systemic effects. Topics: Anti-Inflammatory Agents; Budesonide; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Lymphoma, Follicular; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Mouthwashes; Mucocele; Neutrophil Infiltration; Paraneoplastic Syndromes; Pemphigus	2008

Article

Year

Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2008, Volume: 106, Issue:1

Local immunosuppressive therapies without systemic effects represent a therapeutic advantage in management of immune/inflammatory oral mucosal conditions. Topical budesonide rinses were prescribed to patients with mucosal disease that was resistant to other intervention without side effects. A case of paraneoplastic pemphigus and a patient with oral graft-versus-host disease that had not responded to standard approaches to management were successfully managed with budesonide rinse application. The cases presented represent mucosal conditions that were successfully managed with topical application of budesonide with reduced risk of systemic effects.

Topics: Anti-Inflammatory Agents; Budesonide; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Lymphoma, Follicular; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Mouthwashes; Mucocele; Neutrophil Infiltration; Paraneoplastic Syndromes; Pemphigus

2008